针对病毒聚合酶的小分子药物
Deborah Palazzotti1, Martina Sguilla1, Giuseppe Manfroni1
1Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy.
Pharmaceuticals (Basel, Switzerland)
|May 25, 2024
概括
本综述详细介绍了已批准的病毒聚合酶抑制剂,包括核酸/核酸抑制剂 (NI) 和非核酸抑制剂 (NNI),对于抗病毒药物发现和开发新疗法至关重要.
科学领域:
- 病毒学 病毒学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 病毒聚合酶是病毒复制的必需酶,也是抗病毒疗法的关键标.
- 目前,已批准的聚合酶抑制剂适用于9种人类病毒,包括DNA和RNA病毒.
研究的目的:
- 为获得许可的病毒聚合酶抑制剂提供全面的审查.
- 详细说明每个药物的向病毒,聚合酶,作用机制和生物活性数据.
- 为未来的抗病毒药物发现和开发提供见解.
主要方法:
- 对已批准的针对病毒聚合酶的抗病毒药物的文献综述.
- 抑制剂的分类为核酸/核酸抑制剂 (NI),非核酸抑制剂 (NNI) 和致变物剂.
- 对每个化合物的作用机制和生物活性数据的分析.
主要成果:
- 该审查涵盖了针对9种人类病毒的许可药物.
- 抑制剂被分为NI,NNI和变异原体.
- 详细介绍了针对性病毒,酶,机制和生物活性的详细信息.
结论:
- 经批准的病毒聚合酶抑制剂代表了对抗病毒感染的重大进展.
- 这篇评论为研究人员在抗病毒药物发现方面提供了宝贵的资源.
- 提供的见解可以指导下一代抗病毒疗法的发展.
更多相关视频
相关概念视频
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Retrovirus Life Cycles
45.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.9K
Translesion DNA Polymerases
9.9K
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
9.9K
Ribozymes
12.2K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
12.2K


